FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Emergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide. Given the absence of a current vaccine or specific antiviral treatment, it is urgent to search for FDA-approved drugs that c...
Kaydedildi:
| Yazar: | |
|---|---|
| Diğer Yazarlar: | , , |
| Materyal Türü: | Artículo |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://doi.org/10.1080/07391102.2020.1764393 https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1764393?needAccess=true |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
